Cancer diagnostics is a field filled with skeptics and false hope. Promising biomarkers appear, only to be proven useless, with a regularity that has created an attitude of superficial apathy in much of the clinical world.
Of all the challenges in cancer diagnosis, ovarian cancer is one of the most frustrating—because it's symptomless and good tests for early detection don't exist, women aren't diagnosed in time...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?